Literature DB >> 241786

Mechanism of induction of hepatic microsomal drug metabolizing enzymes by a series of barbiturates.

C Ioannides, D V Parke.   

Abstract

The inducing effect of certain barbiturates (secobarbitone, thiopentone, pentobarbitone, allobarbitone, phenobarbitone and barbitone) on the levels of the hepatic microsomal drug-metabolizing enzymes has been studied in the rat both in vivo and in vitro. The extent of induction was related to the plasma half-lives of the barbiturates; compounds with low rates of metabolism and long half-lives were the most potent inducing agents. The latter (phenobarbitone, pentobarbitone and allobarbitone) were shown by spectral technique to interact with cytochrome P-450 suggesting that their mechanism of enzyme induction was 'substrate induction' in type. Barbiturates containing an allyl group (secobarbitone and allobarbitone) had a weaker inducing effect than expected, possibly due to their destruction of cytochrome P-450. Despite its short plasma half-life of 0-5 h thiopentone was a relatively potent inducer probably due to its metabolism to pentobarbitone, which has a much longer plasma half-life (1-3 h). Barbitone is an effective inducer of the drug-metabolizing enzymes, yet does not interact spectrally with cytochrome P-450; this is in accord with the observations that although there are increases in NADPH-cytochrome c reductase and cytochrome b5, following administration of barbitone there is no increase in cytochrome P-450. Barbiturate pretreatment does not affect the activities of glucose-6-phosphatase, glucose-6-phosphate dehydrogenase or 6-phosphogluconate dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 241786     DOI: 10.1111/j.2042-7158.1975.tb09393.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  14 in total

Review 1.  Phenobarbital induction of cytochrome P-450 gene expression.

Authors:  D J Waxman; L Azaroff
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

2.  Anti-mutagenicity Effects of Vitamin E on Oncology and Non-oncology Hospital Nurses by Ames Assay.

Authors:  Majid Rezaei-Basiri; Hassan Rezazadeh; Iraj Aswadi-Kermani; Mahmud Ghazi-Khansari
Journal:  J Clin Diagn Res       Date:  2013-12-15

3.  Determination of cytochrome P-448 activity in biological tissues.

Authors:  C E Phillipson; P M Godden; P Y Lum; C Ioannides; D V Parke
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

Review 4.  Clinical implications of enzyme induction and enzyme inhibition.

Authors:  B K Park; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 5.  The Role of GABA Receptor Agonists in Anesthesia and Sedation.

Authors:  Janette Brohan; Basavana G Goudra
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

6.  Inhibition of antibacterial activity of himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus, by fatty acid sodium salts.

Authors:  S W Mamber; K W Brookshire; B J Dean; R A Firestone; J E Leet; J A Matson; S Forenza
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Effect of surgery under general anaesthesia on antipyrine clearance.

Authors:  D Pessayre; H Allemand; C Benoist; F Afifi; M François; J P Benhamou
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

8.  Mechanism of the protective action of n-acetylcysteine and methionine against paracetamol toxicity in the hamster.

Authors:  S Pratt; C Ioannides
Journal:  Arch Toxicol       Date:  1985-08       Impact factor: 5.153

9.  Induction of hepatic microsomal CYP4A activity and of peroxisomal beta-oxidation by two non-steroidal anti-inflammatory drugs.

Authors:  E Rekka; E O Ayalogu; D F Lewis; G G Gibson; C Ioannides
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Twenty-four hour toxicity rhythms of sedative-hypnotic drugs in mice.

Authors:  A L Sermons; F H Ross; C A Walker
Journal:  Arch Toxicol       Date:  1980-05       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.